HeslopHE, NgCY, LiC.Long term restoration of immunity against Epstein—Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nature Med1996; 4: 852–6.
2.
WalterEA, GreenbergPD, GilbertMJ.Reconstitution of cellular immunity against cytomegalovirus in recipients of allogenic bone marrow by transfer of T-cell clones from the donor. N Eng J Med1995; 333: 1038–44.
3.
O'ReillyRJ, SmallTN, PapadopoulosE.Biology and adoptive cell therapy of Epstein—Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts. Immunol Rev1997; 157: 217–22.
4.
TanR, XuX, OggGS.Rapid death of adoptively transferred T cells in acquired immunodeficiency syndrome. Blood1999; 93: 1506–10.
5.
VileRG, NelsonJA, CastledonS.Systemic gene therapy of murine melanoma using tissue-specific expression of the HSVtk gene involves an immune component. Cancer Res1994; 54: 6228–34.
6.
FreemanSM, WartenbyKA, FreemanJA.In situ use of suicide genes for cancer therapy. Semin Oncol1996; 23: 135–47.
7.
Leeson-WoodLA, KimWH, KleinmanHK.Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice. Human Gene Ther1991; 55: 5151–5.
8.
RothJA, NguyenD, LawrenceDD.Retrovirus-mediated wild-type p53 gene transfer to tumours of patients with lung cancer. Nature Med1996; 2: 985–91.
9.
DrannofG, JaffeeE, LazenbyA.Vaccination with irradiated tumour cells to secrete murine granulocyte-macrophage colony simulating factor stimulates potent, specific and long-lasting anti-tumour immunity. Proc Natl Acad Sci USA1993; 90: 3539–43.
10.
CouliePG, Van den EyndeBJ, van der BruggenP.Antigens recognized by T-lymphocytes on human tumours. Biochem Soc Trans1997; 25: 544–8.
11.
ColeDJ, WilsonMC, BaronPL.Phase I study of recombinant CEA vaccinia virus vaccine with post vaccination CEA peptide challenge. Hum Gene Ther1996; 7: 1381–94.
12.
Abdel-WahabZ, WeltzC, HesterD.A phase I trial of immunotherapy with interferon-γ gene-modified autologous melanoma cells. Cancer1997; 80: 401–12.
13.
NabelG, GordonD, BishopD.Immune response in human melanoma after transfer of an allogenic class I major histocompatibility complex gene with DNA-liposome complexes. Proc Natl Acad Sci USA1996; 93: 15388–93.
14.
MelcherA, TodrykS, HardwickN.Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nature Med1998; 4: 581–7.
